Sanofi-aventis and DNDi welcome the Clinton Foundation announcement on ACTs and commit to providing fixed-dose combination “ASAQ” at equally low prices

Press Release: Sanofi Aventis and Drugs for Neglected Diseases initiative

Sanofi-aventis and the non-profit Drugs for Neglected Diseases initiative (DNDi) welcome the agreement announced by Clinton Foundation HIV/AIDS Initiative (CHAI) to reduce the volatility and the price levels of Artemisininbased Combination Therapies (ACT). The CHAI’s initiative is consistent with sanofi-aventis and DNDi’ long-standing efforts to make ACTs more affordable and accessible to all malaria patients.

Chagas Disease Partnership Will Deliver Safe, Easy-to-Use Treatment for Children

A new partnership between Lafepe and DNDi will make available the first pediatric formulation of benznidazole to patients by the end of 2009. The drug will be sold at cost, with no profit to the institutions involved in its development, and will be available for distribution worldwide.

Read the Market Watch article >>

Malaria Researcher Calls for Sustained Funding to Fight Scourge

Brian Greenwood, 2008 winner of the Hideyo Noguchi Africa Prize, says that if governments more robustly fund malaria prevention, they can reduce the burden of the disease by up to 90 percent in some areas.

Read this entry on the Wall Street Journal Health Blog >>

Global Health Progress Supports Clinton Foundation Malaria Drug Plan

Dr. Paul Antony, medical director of Global Health Progress, made the following statement in response to the Clinton Foundation’s plan to make malaria drugs more broadly available to the developing world.

Disability, Poverty, Development and Public Health: Part 2

Dorothea Rischewski, GTZ, Germany
Christiane Noe, CBM, Germany
Catherine Naughton, CBM, EU
Allen Foster, CBM/LSHTM, London

Persons with disabilities have the right to access to healthcare and rehabilitation on an equal basis as others

Meeting with Dr. Lorenzo Savioli, WHO's Neglected and Tropical Disease Department

Time: 10-11:30 am

Event Location: Global Health Council

Neglected tropical diseases have afflicted humanity since time immemorial and, in their long histories, have acquired notoriety as disabling and deforming diseases. Today, those most affected are the poorest populations - often living in remote, rural areas, urban slums or in conflict zones.

For Students in Kenya, Medicine Seems to Improve Attention Span

Giving schoolchildren in rural Kenya regular doses of malaria medicine, even if they weren’t obviously sick, seemed to improve their attention span in school, a study in The Lancet has found.

Read the New York Times article >>

Tommy Thompson on Neglected Tropical Diseases

Time: 10:00 AM
Event Location: National Press Club, Zenger Room

Tommy G. Thompson, former Secretary of the US Department of Health and Human Services, will discuss his new role in the global health arena, the fight against neglected tropical diseases, and the importance of "global medical diplomacy."

Making the eHealth Connection

  • July 13 - August 8, 2008
  • Bellagio, Italy

eHealth is defined as the use of information and communications technology to improve the performance of health systems and represents a promising frontier. Members of the international community - donors, governments, industry, researchers and civil society are engaged in this effort to raise the profile of eHealth, form new partnerships and identify promising new areas of work for the Global South.

Pursuing Innovative Solutions to Fight Global Health Epidemics

Working Together to Make a Difference

The research and development (R&D) of innovative new drugs and vaccines is a critical component of improving health care and combating epidemics in developing countries. For some widespread and life-threatening diseases such as malaria, no vaccines exist, while current treatments for diseases such as tuberculosis are becoming less effective due to drug resistance.

Pages